The Biotech landscape has been slowly shifting awareness to the likes of Antibodies & Therapeutics, especially after the President was t...

Recap Sorrento Therapeutics has run over 100% since it hit bottom at $5.77. Hindenburg put out hit piece on SRNE scaring off many retail...

Good news? Sorrento Therapeutics annouces 2 major catalysts in the past week. The first came on August 19,2020. The company announced it ...

Sorrento shareholders have been on a wild ride as of late. I will briefly give you my view of the current events, what my thoughts are o...

Opgen follow up Tweet with PR stating, "As disclosed in OpGen, Inc.’s (NASDAQ: OPGN) (“OpGen” or “the Company”) July 13, 2020 press relea...

Novavax in a recent Phase I study showed that it's vaccine elicited an immune response and was moderately safe. Therefore, the phase I st...

As promised, I have worked with the team on dialing in a tradeable/actionable boom calendar. I suggest you reread the last four articles...

Before I begin, I might as well share with you a snippet about me. I started out my career at 24 as a financial advisor for five years, ...

Dr. Robert Hariri has been making headlines recently and for good reason. Dr. Hariri is the CEO of Celularity Inc. and a straight shooter...

I think we can all agree that if a stock took a 40% decline in just a couple days time, we'd all probably freak out and begin questionin...